These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7407943)

  • 1. Transient lysozymuria during sarcoma I tumor rejection.
    Bordin S; Young ET
    Cell Immunol; 1980 Aug; 54(1):87-97. PubMed ID: 7407943
    [No Abstract]   [Full Text] [Related]  

  • 2. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
    Leffell MS; Coggin JH
    Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
    [No Abstract]   [Full Text] [Related]  

  • 3. [Heterogeneity of murine sarcoma cells for transplantability due to their different susceptibilities to the lytic action of macrophages].
    Ustinov AS; Lavrovskiĭ VA
    Biull Eksp Biol Med; 1988 Mar; 105(3):322-4. PubMed ID: 3349171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lysozymuria in 17 patients with kidney transplants as parameter of acute and chronic rejection].
    Sennekamp J; Ricken D; Siedek M; Hildenbrand G
    Klin Wochenschr; 1973 Aug; 51(15):748-53. PubMed ID: 4582177
    [No Abstract]   [Full Text] [Related]  

  • 5. Some murine allogeneic organ and tumor grafts which are not rejected: the importance of local factors.
    Russell PS
    Cell Immunol; 1981 Aug; 62(2):287-92. PubMed ID: 7026054
    [No Abstract]   [Full Text] [Related]  

  • 6. Muramidase and acute rejection of kidney grafts.
    Leemhuis MP; Spijkerman MG; Swanen-Sierag DH
    Lancet; 1972 Aug; 2(7773):387-8. PubMed ID: 4114765
    [No Abstract]   [Full Text] [Related]  

  • 7. Rejection of sarcoma cells at the site of an inflammatory reaction: macrophages are not the only effector cells.
    Parr IB; Wheeler LE; Alexander P
    Cancer Lett; 1975 Sep; 1(1):49-53. PubMed ID: 797442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysozymuria and renal transplantation.
    Harrison JF; Barnes AD; Blainey JD
    Transplantation; 1972 Apr; 13(4):372-7. PubMed ID: 4552362
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects on in vitro tumor growth of murine macrophages isolated from sarcoma lines differing in immunogenicity and metastasizing capacity.
    Mantovani A
    Int J Cancer; 1978 Dec; 22(6):741-6. PubMed ID: 721327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic enhancement in a syngeneic tumor system.
    Beltz WR; Levy NL
    Surg Forum; 1975; 26():142-4. PubMed ID: 1216091
    [No Abstract]   [Full Text] [Related]  

  • 11. Proteinuria, lysozymuria, and renal transplantation.
    Harrison JF; Barnes AD; Blainey JD
    Br J Surg; 1971 Apr; 58(4):299-300. PubMed ID: 4929357
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rejection mechanisms of xenogeneic tumor graft in the cheek pouch of hamster (author's transl)].
    Shiraishi M
    Fukuoka Igaku Zasshi; 1981 Oct; 72(10):575-88. PubMed ID: 7327500
    [No Abstract]   [Full Text] [Related]  

  • 13. Rejection of tumor cells in vitro.
    Berczi I; Strausbauch P; Sehon AH
    Science; 1973 Jun; 180(4092):1289-91. PubMed ID: 4122513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proceedings: Clinical significance of lysozymuria in renal transplantation].
    Rivolta E; De Vecchi A; Brancaccio D; Graziani G
    Quad Sclavo Diagn; 1973 Mar; 9(1):445-50. PubMed ID: 4596367
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of the A/Ph.MC.S1 tumor graft rejection in syngeneic mice.
    Zákány J; Jánossy T; Németh P; Chihara G; Fachet J; Petri G
    Gan; 1983 Oct; 74(5):712-22. PubMed ID: 6357932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The rate of macrophage inclusion in the elimination of tumor cells when administered to syngeneic animals].
    Lavrovskiĭ VA; Ustinov AS
    Eksp Onkol; 1990; 12(5):35-6. PubMed ID: 2226255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of soluble murine histocompatibility antigens.
    Sagi S; Turianskyj FH; Gyenes L
    Immunol Commun; 1974; 3(1):85-94. PubMed ID: 4823533
    [No Abstract]   [Full Text] [Related]  

  • 18. Macrophage accumulation in transplanted tumors is not dependent on host immune responsiveness or presence of tumor-associated rejection antigens.
    Evans R; Eidlen DM
    J Reticuloendothel Soc; 1981 Nov; 30(5):425-37. PubMed ID: 7321000
    [No Abstract]   [Full Text] [Related]  

  • 19. Cellular stimuli for rejection of sarcoma I tumor allografts by BALB/c recipient mice.
    Smith DM; Fitch FW
    Cell Immunol; 1989 Feb; 118(2):358-67. PubMed ID: 2491961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished cellular cytotoxicity in mice hyperimmunized prior to skin grafting.
    Sugarbaker PH
    Cell Immunol; 1981 Jan; 57(1):99-113. PubMed ID: 6783318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.